|
Maternal age, years
|
29.12 ± 5.12
|
27.77 ± 4.60
|
0.452
|
|
Maternal chronic disease
|
14 (15.1%)
|
3 (27.3%)
|
0.382
|
|
High professional risk
|
19 (20%)
|
2 (16.7%)
|
0.999
|
|
Obstetrical history
|
|
Parity
|
2.24 ± 1.21
|
2.16 ± 1.69
|
0.848
|
|
Live births
|
2.03 ± 0.93
|
2.0 ± 1.41
|
0.918
|
|
Abortions
|
0.21 ± 0.74
|
0.17 ± 0.39
|
0.847
|
|
Parity, with living children (≥1)
|
75 (78.9%)
|
7 (58.3%)
|
0.146
|
|
Complications during pregnancy
|
9 (9.9%)
|
4 (33.3%)
|
0.038
|
|
Medication use during pregnancy
|
16 (16.8%)
|
6 (50%)
|
0.016
|
|
Febrile disease at CMV diagnosis
|
31 (38.8%)
|
1 (8.3%)
|
0.103
|
|
Gestational age at CMV diagnosis:
|
19.50 ± 8.38
|
19.16 ± 13.51
|
0.928
|
|
1st trimester
|
44 (46.3%)
|
3 (25%)
|
0.318
|
|
2nd trimester
|
42 (44.2%)
|
1 (8.3%)
|
0.03
|
|
3rd trimester
|
9 (9.5%)
|
2 (16.7%)
|
0.356
|
|
Maternal serology at CMV diagnosis
|
|
Positive IgG
|
81 (85.3%)
|
12 (100%)
|
<.0001
|
|
IgG Seroconversion
|
79 (83.1%)
|
--
|
--
|
|
Positive IgM
|
72 (75.8%)
|
3 (25%)
|
0.0008
|
|
Low avidity IgG
|
33 (34.7%)
|
--
|
--
|
